Total Payments
$1,634
2023 Payments
$53.32
Companies
8
Transactions
16
Medicare Patients
1,462
Medicare Billing
$152,281
Payment Breakdown by Category
Food & Beverage$1,634 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,634 | 16 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $705.65 | 7 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $236.63 | 2 | $0 (2018) |
| GlaxoSmithKline, LLC. | $190.56 | 2 | $0 (2019) |
| SANOFI PASTEUR INC. | $124.39 | 1 | $0 (2019) |
| PFIZER INC. | $120.39 | 1 | $0 (2018) |
| Amgen Inc. | $104.56 | 1 | $0 (2018) |
| AbbVie Inc. | $98.61 | 1 | $0 (2021) |
| Genentech USA, Inc. | $53.37 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $53.32 | 1 | AstraZeneca Pharmaceuticals LP ($53.32) |
| 2022 | $427.41 | 4 | AstraZeneca Pharmaceuticals LP ($427.41) |
| 2021 | $198.55 | 2 | AstraZeneca Pharmaceuticals LP ($99.94) |
| 2020 | $53.37 | 1 | Genentech USA, Inc. ($53.37) |
| 2019 | $439.93 | 4 | GlaxoSmithKline, LLC. ($190.56) |
| 2018 | $461.58 | 4 | E.R. Squibb & Sons, L.L.C. ($236.63) |
All Payment Transactions
16 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/16/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $53.32 | General |
| Category: Respiratory | ||||||
| 09/14/2022 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $92.96 | General |
| Category: Respiratory | ||||||
| 05/26/2022 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/11/2022 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $125.82 | General |
| Category: Respiratory | ||||||
| 03/03/2022 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $83.63 | General |
| Category: Respiratory | ||||||
| 10/16/2021 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $99.94 | General |
| 03/13/2021 | AbbVie Inc. | CREON (Drug) | Food and Beverage | In-kind items and services | $98.61 | General |
| Category: ENDOCRINOLOGY | ||||||
| 01/18/2020 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $53.37 | General |
| Category: Virology & Specialty Care | ||||||
| 09/26/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $124.98 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/14/2019 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $91.03 | General |
| Category: RESPIRATORY | ||||||
| 04/11/2019 | SANOFI PASTEUR INC. | FLUZONE HIGH-DOSE (Drug), FLUBLOK QUADRIVALENT | Food and Beverage | In-kind items and services | $124.39 | General |
| Category: VACCINES | ||||||
| 03/19/2019 | GlaxoSmithKline, LLC. | BEXSERO (Biological) | Food and Beverage | In-kind items and services | $99.53 | General |
| Category: VACCINES | ||||||
| 10/17/2018 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $118.29 | General |
| Category: Cardiovascular | ||||||
| 03/07/2018 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $120.39 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/20/2018 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $104.56 | General |
| 01/30/2018 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $118.34 | General |
| Category: Cardiovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 202 | 260 | $86,716 | $16,583 |
| 2022 | 9 | 426 | 634 | $207,020 | $51,972 |
| 2021 | 8 | 382 | 555 | $155,753 | $45,965 |
| 2020 | 11 | 452 | 613 | $151,102 | $37,761 |
Total Patients
1,462
Total Services
2,062
Medicare Billing
$152,281
Procedure Codes
31
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 98 | 148 | $53,872 | $8,433 | 15.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 37 | 37 | $13,764 | $4,752 | 34.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 67 | 75 | $19,080 | $3,399 | 17.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 180 | 377 | $137,445 | $29,500 | 21.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 94 | 94 | $34,968 | $12,306 | 35.2% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 17 | 17 | $8,017 | $2,853 | 35.6% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 36 | 36 | $6,613 | $2,502 | 37.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 26 | 36 | $9,306 | $1,734 | 18.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 11 | 11 | $5,218 | $1,027 | 19.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 28 | 28 | $2,292 | $831.20 | 36.3% |
| 0004A | Adm sarscov2 30mcg/0.3ml bst | Office | 2022 | 17 | 18 | $1,914 | $710.66 | 37.1% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 17 | 17 | $1,247 | $507.40 | 40.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 189 | 357 | $105,949 | $28,725 | 27.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 67 | 67 | $21,172 | $8,934 | 42.2% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2021 | 13 | 13 | $6,045 | $2,196 | 36.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 42 | 47 | $9,635 | $2,168 | 22.5% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 16 | 16 | $7,200 | $1,891 | 26.3% |
| 90653 | Vaccine for influenza for injection into muscle, inactivated | Office | 2021 | 19 | 19 | $3,059 | $1,131 | 37.0% |
| 0004A | Fee covid-19 vac 1 res | Office | 2021 | 13 | 13 | $1,313 | $524.03 | 39.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 23 | 23 | $1,380 | $394.40 | 28.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 185 | 338 | $100,386 | $21,242 | 21.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 60 | 60 | $19,014 | $7,021 | 36.9% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2020 | 18 | 18 | $8,410 | $3,097 | 36.8% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 33 | 33 | $4,941 | $1,976 | 40.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 35 | 36 | $7,265 | $1,280 | 17.6% |
About Dr. Raphael Peralta, MD
Dr. Raphael Peralta, MD is a Family Medicine healthcare provider based in University Place, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/07/2008. The National Provider Identifier (NPI) number assigned to this provider is 1386807725.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Raphael Peralta, MD has received a total of $1,634 in payments from pharmaceutical and medical device companies, with $53.32 received in 2023. These payments were reported across 16 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($1,634).
As a Medicare-enrolled provider, Peralta has provided services to 1,462 Medicare beneficiaries, totaling 2,062 services with total Medicare billing of $152,281. Data is available for 4 years (2020–2023), covering 31 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Other Specialties Family Medicine, Family Medicine
- Location University Place, WA
- Active Since 07/07/2008
- Last Updated 12/08/2020
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1386807725
Products in Payments
- ELIQUIS (Drug) $357.02
- BREZTRI (Drug) $272.10
- LOKELMA (Drug) $125.00
- FARXIGA (Drug) $124.98
- FLUZONE HIGH-DOSE (Drug) $124.39
- BEXSERO (Biological) $99.53
- CREON (Drug) $98.61
- TRELEGY ELLIPTA (Drug) $91.03
- FASENRA (Biological) $83.63
- Xofluza (Drug) $53.37
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in University Place
Dr. Stanley Flemming, D.o, D.O
Family Medicine — Payments: $2,631
Family Medicine $2,631
Laural Schaberg, Arnp, ARNP
Family Medicine — Payments: $2,096
Family Medicine $2,096
Dr. Michael Jackson, M.d, M.D
Family Medicine — Payments: $2,094
Family Medicine $2,094
Dr. Andrea Friesen, M.d, M.D
Family Medicine — Payments: $952.90
Family Medicine $952.90
Dr. Robert Wilson, Md, MD
Family Medicine — Payments: $78.57
Family Medicine $78.57
Michael Johnson, Md, MD
Family Medicine — Payments: $35.09
Family Medicine $35.09